Jump to content
  • Recently Browsing   0 members

    No registered users viewing this page.

Purple Power

Updated APPROVED: Marijuana-based epilepsy drug gets positive review from FDA

Rate this topic

Recommended Posts

Marijuana-based epilepsy drug gets positive review from FDA

Matthew Perrone

 

WASHINGTON — A closely watched medicine made from the marijuana plant reduces seizures in children with severe forms of epilepsy and warrants approval in the United States, health officials said Tuesday.

 

British drugmaker GW Pharmaceuticals is seeking permission to sell its purified form of an ingredient found in cannabis — one that doesn’t get users high — as a medication for rare, hard-to-treat seizures in children. If successful, the company’s liquid formula would be the first government-approved drug derived from the cannabis plant in the U.S.....

 

 

 

 

 

https://chicago.suntimes.com/cannabis/marijuana-epilepsy-drug-positive-review-fda-gw-pharmaceuticals-cannabis/


gallery_2188_61_23224.png  

Classy, sassy, and a bit of a smart assy

Share this post


Link to post
Share on other sites

Marijuana-based seizure treatment gets positive review from FDA

Associated Press

 

4/17/18

 

A closely watched medicine made from the marijuana plant reduces seizures in children with severe forms of epilepsy and warrants approval in the United States, health officials said Tuesday.

 

British drugmaker GW Pharmaceuticals is seeking permission to sell its purified form of an ingredient found in cannabis — one that doesn't get users high — as a medication for rare, hard-to-treat seizures in children. If successful, the company's liquid formula would be the first government-approved drug derived from the cannabis plant in the U.S.......

 

 

 

http://www.orlandosentinel.com/news/nationworld/ct-marijuana-medicine-fda-review-20180417-story.html

 


gallery_2188_61_23224.png  

Classy, sassy, and a bit of a smart assy

Share this post


Link to post
Share on other sites

Could This Be The First Cannabis-Based Drug To Get FDA Approval?

The first cannabis-based drug to get FDA approval could be a strawberry-flavored, oral CBD solution designed for kids with epilepsy.

 

Adam Drury

 

Nearly a year ago, UK drug manufacturer GW Pharmaceuticals filed its breakthrough epilepsy treatment for approval by U.S. regulators. The drug, Epidiolex, is derived from cannabidiol, or CBD, a non-psychoactive constituent of the cannabis plant. And on Tuesday, the FDA issued a report citing the “substantial evidence” GW Pharma had provided on the drug’s effectiveness. Could Epidiolex be the first cannabis-based drug to get FDA Approval?

Epidiolex: The Cannabis-Based Drug That Can Beat Epilepsy

There are many different types of epilepsy. But Dravet syndrome and Lennox-Gastaut syndrome are two of the severest forms of the disease. They’re also two of the hardest to treat.......

 

 

https://hightimes.com/news/first-cannabis-based-drug-fda-approval/


gallery_2188_61_23224.png  

Classy, sassy, and a bit of a smart assy

Share this post


Link to post
Share on other sites

GW Pharmaceuticals’ CEO talks Epidiolex, future of cannabidiol medicine

“It is by far the most important product that we are developing today.”

 

Apr 18, 2018

This is a make-or-break spring for GW Pharmaceuticals and its billion-dollar investment in a cannabidiol-based drug.

 

The London-based firm aims to develop the first FDA-approved medicine from plant-derived cannabis compounds. The U.S. Food and Drug Administration could decide as early as June 27 whether Epidiolex, a CBD oral solution, could be prescribed to patients with rare epilepsy conditions.

 

And as GW prepares for a Thursday hearing of a FDA advisory committee, it appears the odds are in the company’s favor.......

 

 

 

https://www.thecannabist.co/2018/04/18/gw-pharmaceuticals-epidiolex-cbd-justin-grover/103667/

 


gallery_2188_61_23224.png  

Classy, sassy, and a bit of a smart assy

Share this post


Link to post
Share on other sites

Cannabis-derived epilepsy drug one step closer to FDA approval

 

WASHINGTON, D.C. – An FDA committee recently recommended the approval of a marijuana-derived drug to treat epilepsy. This would be the first prescription medicine derived from plant-based cannabidiol (CBD) in the United States.

 

CNN reports the drug, Epidiolex, is intended to treat severe forms of epilepsy. The FDA has approved synthetic versions of cannabinoid chemicals in the past, usually for cancer pain relief.....

 

 

https://kobi5.com/news/cannabis-derived-epilepsy-drug-one-step-closer-to-fda-approval-75834/


gallery_2188_61_23224.png  

Classy, sassy, and a bit of a smart assy

Share this post


Link to post
Share on other sites

F.D.A. Panel Recommends Approval of Cannabis-Based Drug for Epilepsy

WASHINGTON — A Food and Drug Administration advisory panel on Thursday unanimously recommended approval of an epilepsy medication made with an ingredient found in marijuana. If the agency follows the recommendation, as is expected, the drug would be the first cannabis-derived prescription medicine available in the United States.

The drug, called Epidiolex, is made by GW Pharmaceuticals, a British company. Its active ingredient, cannabidiol, also called CBD, is one of the chemical compounds found in the cannabis plant, but it does not contain the properties that make people high.....

 

 

 

 

 

 

https://www.nytimes.com/2018/04/19/health/epidiolex-fda-cannabis-marajuana.html

 


gallery_2188_61_23224.png  

Classy, sassy, and a bit of a smart assy

Share this post


Link to post
Share on other sites

FDA Approves Cannabis Based Drug

The Food and Drug Administration has approved a drug called Epidiolex to help treat epileptic seizures.

Posted: Jun. 26, 2018 5:51 PM

 

CNN -- The Food and Drug Administration has approved a drug called Epidiolex to help treat epileptic seizures.  

 

It is the first time that the FDA has approved a Cannabis based drug. 

 

Epidiolex is a twice-daily oral medication that can be used for patients two years of age and older, who suffer from two types of Epilepsy.  Davert syndrome is a genetic dysfunctin of the brain that begins in the first twelve months of life. Lennox-Gastaut Syndrome causes multiple types of seizures and begins between the ages of three and five years old........

 

 

 

http://www.kdrv.com/content/news/FDA-Approves-Cannibusmqe--486633091.html


gallery_2188_61_23224.png  

Classy, sassy, and a bit of a smart assy

Share this post


Link to post
Share on other sites

×